1. Lei, Yu, Lei, Yan, Shi, Xiang, Wang, Jingjing. 2022. EML4-ALK fusion gene in non-small cell lung cancer. In Oncology letters, 24, 277. doi:10.3892/ol.2022.13397. https://pubmed.ncbi.nlm.nih.gov/35928804/
2. Soda, Manabu, Choi, Young Lim, Enomoto, Munehiro, Sugiyama, Yukihiko, Mano, Hiroyuki. 2007. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. In Nature, 448, 561-6. doi:. https://pubmed.ncbi.nlm.nih.gov/17625570/
3. Elshatlawy, Mariam, Sampson, Josephina, Clarke, Katy, Bayliss, Richard. 2023. EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries. In Molecular oncology, 17, 950-963. doi:10.1002/1878-0261.13446. https://pubmed.ncbi.nlm.nih.gov/37149843/
4. Aydemirli, Mehtap Derya, van Eendenburg, Jaap D H, van Wezel, Tom, Kapiteijn, Ellen, Morreau, Hans. 2021. Targeting EML4-ALK gene fusion variant 3 in thyroid cancer. In Endocrine-related cancer, 28, 377-389. doi:10.1530/ERC-20-0436. https://pubmed.ncbi.nlm.nih.gov/33878728/
5. Misove, Adela, Vicha, Ales, Zapotocky, Michal, Broz, Petr, Krskova, Lenka. 2021. An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma. In Genes, chromosomes & cancer, 60, 837-840. doi:10.1002/gcc.22990. https://pubmed.ncbi.nlm.nih.gov/34378283/
智鼠故事 
